The evidence base for the efficacy of insulin pump therapy in type 2 diabetes mellitus (T2DM) has been inconsistent to date. However, a recent large-scale randomized controlled trial comparing pump treatment with multiple daily insulin injections in patients with poorly controlled T2DM has shown substantial improvement in glycaemic control with pump therapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats
BMC Musculoskeletal Disorders Open Access 30 May 2022
-
A multimode metamaterial for a compact and robust dualband wireless power transfer system
Scientific Reports Open Access 11 November 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pickup, J. C. Insulin-pump therapy for type 1 diabetes mellitus. N. Engl. J. Med. 366, 1616–1624 (2012).
National Institute for Health and Care Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE Technology Appraisals [TA151] [online], (2008).
Raskin, P. et al. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26, 2598–2603 (2003).
Berthe, E. et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous insulin infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm. Metab. Res. 39, 224–229 (2007).
Reznik, Y. et al. Insulin pump treatment compared with multiple daily insulin injections for the treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet http://dx.doi.org/10.1016/S0140–6736(14)61037–0.
Dodd, A. H. et al. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004. Curr. Med. Res. Opin. 25, 1605–1613 (2009).
Edelman, S. et al. Insulin pump therapy in patients with type 2 diabetes. Safely improved glycemic control using a simple insulin dosing regimen. Diabet. Technol. Therapeut. 12, 627–633 (2010).
Leinung, M. et al. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections. Endocr. Pract. 19, 9–13 (2013).
Parkner, T. et al. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in type 2 diabetes. Diabet. Med. 25, 585–591 (2008).
King, A. B., Clark, D. & Wolfe, G. S. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes. Diabet. Technol. Therapeut. 14, 900–903 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.C.P. has received speaker and/or consultancy fees from manufacturers of insulin pumps, including Cellnovo, Cequr, Medtronic and Roche.
Rights and permissions
About this article
Cite this article
Pickup, J. Insulin pump therapy for type 2 diabetes mellitus. Nat Rev Endocrinol 10, 647–649 (2014). https://doi.org/10.1038/nrendo.2014.142
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2014.142
This article is cited by
-
An injectable and biodegradable zwitterionic gel for extending the longevity and performance of insulin infusion catheters
Nature Biomedical Engineering (2023)
-
Effects of continuous subcutaneous insulin infusion on the microstructures, mechanical properties and bone mineral compositions of lumbar spines in type 2 diabetic rats
BMC Musculoskeletal Disorders (2022)
-
A multimode metamaterial for a compact and robust dualband wireless power transfer system
Scientific Reports (2021)
-
Pursuit of a perfect insulin
Nature Reviews Drug Discovery (2016)